23.29
+0.11(+0.47%)
Currency In USD
| Previous Close | 23.29 |
| Open | 23.29 |
| Day High | 24.18 |
| Day Low | 23.29 |
| 52-Week High | 28.5 |
| 52-Week Low | 3.9 |
| Volume | 2,014 |
| Average Volume | 12,758 |
| Market Cap | 35.8M |
| PE | -28.75 |
| EPS | -0.81 |
| Moving Average 50 Days | 22.03 |
| Moving Average 200 Days | 14.45 |
| Change | 0.11 |
If you invested $1000 in Precipio, Inc. (PRPO) since IPO date, it would be worth $8.63 as of December 25, 2025 at a share price of $23.29. Whereas If you bought $1000 worth of Precipio, Inc. (PRPO) shares 5 years ago, it would be worth $570.83 as of December 25, 2025 at a share price of $23.29.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting
GlobeNewswire Inc.
Dec 05, 2025 3:00 PM GMT
Joint study conducted with Memorial Sloan Kettering Cancer Center demonstrates clear, positive impacts on patient careNEW HAVEN, Conn., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) will be pre
Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact
GlobeNewswire Inc.
Dec 04, 2025 1:00 PM GMT
NEW HAVEN, Conn., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Precipio, Inc. reports that the Company recently identified a single, limited scope unauthorized access to a specific data folder stored within its secure cloud file environment. The incident was
Precipio Announces its Q3-2025 Financial Results
GlobeNewswire Inc.
Nov 14, 2025 9:30 PM GMT
Over $450,000 Adjusted EBITDA and $275,000 positive operating cash flow for the quarterNEW HAVEN, Conn., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), filed its 10-Q report today. The followin